Suppliers / Saptagir Laboratories

Saptagir Laboratories

India 49 employees Updated 9 July 2026

Saptagir Laboratories is an API manufacturer based in India. It holds 12 active US drug master files across a filed portfolio of 4 molecules. Customs aggregates show $981K of exports covering 37 molecules to 14 destinations in 2025.

12
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Medak, India 3016470054

What they file, and where

Molecule Regulators Docs
Ezetimibe US FDA 4
Tafamidis US FDA 4
Edoxaban US FDA 2
Terbinafine US FDA 2

Also appears on these molecule pages

Edoxaban contract manufacturing Ezetimibe contract manufacturing Tafamidis contract manufacturing Terbinafine API Zavegepant contract manufacturing

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $189K 4
2025 Not reported $981K 14
2024 Not reported $489K 7
2023 Not reported $711K 10

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Saptagir Laboratories

Does Saptagir Laboratories hold a US DMF or a CEP?
Saptagir Laboratories holds 12 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Saptagir Laboratories FDA-registered?
One site operated by Saptagir Laboratories carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Saptagir Laboratories manufacture?
1 registered site is on record, in India (Medak). Every site is listed on this page with the register it came from.
What does Saptagir Laboratories make?
4 molecules are on record against Saptagir Laboratories, including Ezetimibe, Tafamidis, Edoxaban and Terbinafine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Saptagir Laboratories comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Dr Reddy's Laboratories shares 4 molecules MSN Laboratories shares 3 molecules Apitoria Pharma shares 3 molecules Alivus Life Sciences shares 3 molecules Neuland Laboratories shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts